Sign in
4

Changes in Ownership

ORAMED PHARMACEUTICALS INC. Filed Acc 0001213900-17-008889

Director acquired 11,262 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Sank Leonard Director 2017-08-15 Option exercise +11,262 $6.00 $67,572 282,158 D
Derivatives
Sank Leonard Director 2017-08-15 Option exercise · Warrant (right to buy) −11,262 $1.18 $13,285 0 D
Loading xslF345X03/f4081517sank_oramedpharma.xml…